Biomarker discovery: proteome fractionation and separation in biological samples.
about
Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometryFundamentals and application of magnetic particles in cell isolation and enrichment: a reviewCitrullination of myofilament proteins in heart failure.Total, membrane, and immunogenic proteomes of macrophage- and tick cell-derived Ehrlichia chaffeensis evaluated by liquid chromatography-tandem mass spectrometry and MALDI-TOF methodsDown-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysisProteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.Cardiovascular proteomics: implications for clinical applicationsSub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomicsProteomic discovery of diabetic nephropathy biomarkers.Genomes, proteomes, and the central dogma.Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.Murine model of surgically induced acute aortic dissection type AThe proteomics big challenge for biomarkers and new drug-targets discovery.Liquid-phase-based separation systems for depletion, prefractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis--an update covering the period 2008-2011Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.Immunoaffinity capillary electrophoresis as a powerful strategy for the quantification of low-abundance biomarkers, drugs, and metabolites in biological matrices.Multidimensional protein identification technology for clinical proteomic analysis.Role of proteomic technologies in understanding risk of arterial thrombosis.Addressing the needs of traumatic brain injury with clinical proteomics.Identification of Tengfu Jiangya Tablet Target Biomarkers with Quantitative Proteomic Technique.New insight into neurodegeneration: the role of proteomics.The potential impact of recent insights into proteomic changes associated with glaucoma.Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372.A simple and efficient method for processing of cell lysates for two-dimensional gel electrophoresis.Differential proteomics of sperm: insights, challenges and future prospects.Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung.Thymic function in the regulation of T cells, and molecular mechanisms underlying the modulation of cytokines and stress signaling (Review).Disparities between immobilized enzyme and solution based digestion of transferrin with trypsin.Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery.
P2860
Q24645983-4D904A94-3A6D-4B68-91ED-0ED057893E9AQ30395055-1FA7648B-2FFF-4D56-9C58-7E4AF1E0F7C9Q30670009-6F69A96C-F6B5-4407-8B1B-58DD6C3AE769Q33361105-08FA2B47-64CA-4467-9DAC-60107F95E597Q33475812-DF76C3FF-54A2-4C3E-9CA4-F55C9525DEE1Q33514542-C04E8C18-E4AC-4121-9FAC-05AFF0FC48EBQ33520447-F5A0D023-E47B-473C-A97D-C557E4C0251EQ33579184-ABCE51E0-FCE7-4B71-A12E-088C5DDA2FE3Q33912875-FA6F6626-002D-4F6A-99D8-91EBC1B43DA3Q34330236-CDC9D7BF-7A40-41C7-B86B-6434C0A3CF6DQ35436208-EFD1139C-8642-4C98-A920-30788400ACBEQ35917235-AE722B66-0B60-4F8A-9F7E-4111503CCC19Q36266627-A518D0BF-05E8-49BF-8156-1F21FAA3DFA0Q36432402-2EEE2137-3BFD-49DB-A15E-C0317518B6B6Q36452318-DCFCACE6-6D3A-4949-BB7A-5BB899BE7517Q36467223-1C8964F7-CF91-4DC5-87DC-4F4CF92C98F4Q36828359-2AEE770B-624D-4CA9-BB62-BB7F1472E727Q37137414-2C449148-027F-4169-B579-DAB758104FCBQ37519665-5E7EB965-B6EE-4415-BCBF-6A77A11CCE2DQ37610314-438E4D3A-6986-4A24-BAA9-D11C0D10ABE5Q37685775-2A2A5B18-86A2-4244-95E3-3C9B39AD6051Q37734337-62520854-DE92-4FAA-9459-8094E8AF6EB0Q38170010-2DDB488B-723B-4C03-BAB4-0CBD22A6B449Q39167734-F4621278-F4AA-4526-9422-92DE411DECC7Q39373463-119074F7-1D3F-4D78-B414-AF5E592628EAQ39690429-97127709-E10F-49DB-B4F0-FCB9856D2D61Q39809269-EE7CBC26-404B-4732-B10E-0F5FA019C368Q41683421-89CF5C37-9D29-4274-B5F3-6295AF0C2FF6Q47749841-CB695FAE-7F22-4BC0-B870-07D64D770916Q53126854-88EDA260-051E-4CDF-9B1A-1737FE64D5AAQ55518386-A05C9F0E-A7E5-4E99-9C68-B71977F3252D
P2860
Biomarker discovery: proteome fractionation and separation in biological samples.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarker discovery: proteome fractionation and separation in biological samples.
@en
Biomarker discovery: proteome fractionation and separation in biological samples.
@nl
type
label
Biomarker discovery: proteome fractionation and separation in biological samples.
@en
Biomarker discovery: proteome fractionation and separation in biological samples.
@nl
prefLabel
Biomarker discovery: proteome fractionation and separation in biological samples.
@en
Biomarker discovery: proteome fractionation and separation in biological samples.
@nl
P2093
P2860
P1476
Biomarker discovery: proteome fractionation and separation in biological samples.
@en
P2093
Jennifer E Van Eyk
Peter Matt
Zongming Fu
P2860
P356
10.1152/PHYSIOLGENOMICS.00282.2007
P577
2007-12-27T00:00:00Z